The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024

Amendment to Schedule 17

This section has no associated Explanatory Memorandum

141.  In Schedule 17 (exemption for sale, supply or administration by certain persons)(1)—

(a)in the table in Part 1, in column 1 in entry 10, omit “EU marketing authorisations”;

(b)in the table in Part 4, in columns 1 and 2 in entry 9, omit “EU marketing authorisation”.

(1)

relevant amendments were made to Schedule 17 by S.I. 2019/775 as amended by S.I. 2020/1488.